Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Marc Tessier-Lavigne. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Marc Tessier-Lavigne har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DNLI / Denali Therapeutics Inc. Director 1.886.576
US:REGN / Regeneron Pharmaceuticals, Inc. Director 2.434
US:AGIO / Agios Pharmaceuticals, Inc. Director 48.875
US:JUNO / Juno Therapeutics, Inc. Director 12.000
US:PFE / Pfizer Inc. Director 29.100
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Marc Tessier-Lavigne. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AGIO / Agios Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AGIO / Agios Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2013-07-24 AGIO Tessier-Lavigne Marc 55.555 18,0000 55.555 18,0000 999.990 331 49.5000 1.749.982 175,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Insidersalg AGIO / Agios Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AGIO / Agios Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AGIO / Agios Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Marc Tessier-Lavigne som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-05 2025-06-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 6.037 1.886.576 0,32
2024-06-04 2024-05-31 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 5.967 1.880.539 0,32
2023-06-05 2023-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 4.216 1.874.572 0,23
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 2.434 7,27
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 2.434 7,27
2022-11-28 2022-11-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -20.000 1.870.356 -1,06 30,48 -609.600 57.008.451
2022-11-03 2022-11-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -11.252 1.890.356 -0,59 30,33 -341.273 57.334.497
2022-11-03 2022-11-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.748 1.901.608 -0,46 30,20 -264.190 57.428.562
2022-10-03 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.612 2.269 -61,42 718,00 -2.593.416 1.629.142
2022-10-03 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.612 5.881 159,19 413,33 1.492.948 2.430.794
2022-10-03 2022-09-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.428 2.269 -60,17 698,00 -2.392.744 1.583.762
2022-10-03 2022-09-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.428 5.697 151,08 413,33 1.416.895 2.354.741
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -20 2.269 -0,87 704,83 -14.097 1.599.259
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16 2.289 -0,69 702,36 -11.238 1.607.702
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -80 2.305 -3,35 699,82 -55.986 1.613.085
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -208 2.385 -8,02 698,44 -145.276 1.665.779
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -160 2.593 -5,81 697,29 -111.566 1.808.073
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -85 2.753 -3,00 696,13 -59.171 1.916.446
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -554 2.838 -16,33 691,59 -383.141 1.962.732
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -692 3.392 -16,94 690,65 -477.930 2.342.685
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.009 4.084 -19,81 689,56 -695.766 2.816.163
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -637 5.093 -11,12 688,71 -438.708 3.507.600
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -321 5.730 -5,30 687,90 -220.816 3.941.667
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -16 6.051 -0,26 686,89 -10.990 4.156.371
2022-10-03 2022-09-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.798 6.067 167,39 413,33 1.569.827 2.507.673
2022-09-30 2022-09-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.423 1.910.356 -0,23 31,08 -137.467 59.373.864
2022-09-30 2022-09-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -15.577 1.914.779 -0,81 30,74 -478.837 58.860.306
2022-08-25 2022-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -100 1.930.356 -0,01 32,43 -3.243 62.601.445
2022-08-25 2022-08-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -19.900 1.930.456 -1,02 31,61 -629.039 61.021.714
2022-07-27 2022-07-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -200 1.950.356 -0,01 36,15 -7.230 70.505.369
2022-07-27 2022-07-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -19.800 1.950.556 -1,00 35,60 -704.880 69.439.794
2022-06-28 2022-03-23 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -11.598 2.024.370 -0,57 34,14 -395.956 69.111.992
2022-06-28 2022-03-23 4/A DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8.402 2.035.968 -0,41 33,40 -280.627 68.001.331
2022-06-27 2022-06-24 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -6.766 1.970.356 -0,34 31,08 -210.261 61.230.980
2022-06-27 2022-06-24 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -39.984 1.977.122 -1,98 30,53 -1.220.708 60.361.337
2022-06-27 2022-06-23 4 DNLI Denali Therapeutics Inc.
Common Stock
D - Sale to Issuer -13.250 2.017.106 -0,65 31,10 -412.076 62.732.198
2022-06-06 2022-06-02 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 5.986 2.030.356 0,30
2022-03-25 2022-03-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -11.598 2.024.370 -0,57 34,14 -395.956 69.111.992
2022-03-25 2022-03-23 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8.402 2.035.968 -0,41 33,40 -280.627 68.001.331
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7.439 0 -100,00
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.439 2.269 -76,63 690,00 -5.132.910 1.565.610
2022-03-23 2022-03-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.439 9.708 327,85 380,95 2.833.887 3.698.263
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7.830 0 -100,00
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7.830 2.269 -77,53 680,00 -5.324.400 1.542.920
2022-03-18 2022-03-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7.830 10.099 345,09 376,69 2.949.483 3.804.192
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.361 0 -100,00
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4.361 2.269 -65,78 675,00 -2.943.675 1.531.575
2022-03-18 2022-03-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4.361 6.630 192,20 374,12 1.631.537 2.480.416
2022-02-17 2021-12-13 5 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -200.000 2.044.370 -8,91
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 2.707 2.707
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 191 2.269 9,19
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -800 78.848 -1,00 45,72 -36.576 3.604.931
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -6.002 79.648 -7,01 45,31 -271.951 3.608.851
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -900 79.173 -1,12 45,71 -41.139 3.618.998
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -5.625 80.073 -6,56 45,31 -254.869 3.628.108
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.377 78.848 -4,11 45,59 -153.957 3.594.680
2021-12-30 2021-12-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.343 82.225 -3,91 45,13 -150.870 3.710.814
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10.704 85.650 -11,11 43,88 -469.692 3.758.322
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10.700 85.698 -11,10 43,87 -469.409 3.759.571
2021-12-30 2021-12-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -10.700 85.568 -11,11 43,88 -469.516 3.754.724
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.646 96.354 -3,65 44,37 -161.773 4.275.227
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.602 96.398 -3,60 44,38 -159.857 4.278.143
2021-12-30 2021-12-28 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.732 96.268 -3,73 44,37 -165.589 4.271.411
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100.000 100.000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100.000 100.000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift 100.000 100.000
2021-12-30 2021-10-04 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -300.000 2.244.370 -11,79
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.784 0 -100,00
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3.784 2.078 -64,55 665,00 -2.516.360 1.381.870
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3.784 5.862 182,10 371,40 1.405.378 2.177.147
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.250 0 -100,00
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.250 0 -100,00
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -4.250 8.500 -33,33
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -139 2.078 -6,27 652,26 -90.664 1.355.396
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -249 2.217 -10,10 651,54 -162.233 1.444.464
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -56 2.466 -2,22 650,33 -36.418 1.603.714
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 2.522 -4,69 649,35 -80.519 1.637.661
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -381 2.646 -12,59 648,25 -246.983 1.715.270
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -425 3.027 -12,31 647,39 -275.141 1.959.650
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -354 3.452 -9,30 646,24 -228.769 2.230.820
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61 3.806 -1,58 645,21 -39.358 2.455.669
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -844 3.867 -17,92 644,52 -543.975 2.492.359
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.549 4.711 -24,74 643,33 -996.518 3.030.728
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.645 6.260 -20,81 642,54 -1.056.978 4.022.300
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -952 7.905 -10,75 641,56 -610.765 5.071.532
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -981 8.857 -9,97 640,61 -628.438 5.673.883
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1.260 9.838 -11,35 639,45 -805.707 6.290.909
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2.098 11.098 -15,90 638,46 -1.339.489 7.085.629
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -816 13.196 -5,82 637,71 -520.371 8.415.221
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -816 14.012 -5,50 636,64 -519.498 8.920.600
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4.250 14.828 40,18 273,67 1.163.098 4.057.979
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4.250 14.828 40,18 273,67 1.163.098 4.057.979
2021-09-15 2021-09-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4.250 10.578 67,16 273,67 1.163.098 2.894.881
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -27.245 0 -100,00
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -27.830 0 -100,00
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -39.303 7.862 -83,33
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -700 2.544.370 -0,03 71,06 -49.744 180.810.565
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -93.678 2.545.070 -3,55 70,34 -6.589.779 179.032.949
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 27.245 2.638.748 1,04 19,50 531.278 51.455.586
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 27.830 2.611.503 1,08 18,92 526.544 49.409.637
2021-06-08 2021-06-07 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 39.303 2.583.673 1,54 18,00 707.454 46.506.114
2021-06-04 2021-06-02 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 6.222 6.222
2021-06-04 2021-06-02 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 2.074 2.544.370 0,08
2021-05-24 2021-05-24 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.806 2.542.296 -0,35 60,02 -528.580 152.601.317
2021-05-24 2021-05-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -37.957 2.551.102 -1,47 60,13 -2.282.468 153.405.417
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -98 2.589.059 0,00 61,20 -5.998 158.450.411
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.139 2.589.157 -0,12 60,08 -188.591 155.556.553
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.184 2.592.296 -0,24 57,60 -356.167 149.303.288
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -29.593 2.598.480 -1,13 56,91 -1.684.019 147.869.103
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14.223 2.628.073 -0,54 55,61 -790.884 146.136.627
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.031 2.642.296 -0,04 71,35 -73.563 188.530.462
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.482 2.643.327 -0,13 69,59 -242.309 183.946.483
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.011 2.646.809 -0,23 68,50 -411.778 181.317.004
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14.945 2.652.820 -0,56 67,57 -1.009.834 179.251.047
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.316 2.667.765 -0,68 66,55 -1.219.003 177.550.432
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -37.445 2.686.081 -1,37 65,63 -2.457.665 176.298.240
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.770 2.723.526 -0,68 64,36 -1.208.056 175.288.857
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 3.613 3.613
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 248 2.078 13,55
2020-06-18 2020-06-16 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -400.000 2.739.043 -12,74 26,10 -10.440.000 71.489.022
2020-06-05 2020-06-03 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 3.253 3.253
2020-06-05 2020-06-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 15.183 15.183
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -15.000 0 -100,00
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -100 1.830 -5,18 566,01 -56.601 1.035.798
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -900 1.930 -31,80 565,35 -508.815 1.091.126
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -6.600 2.830 -69,99 564,45 -3.725.370 1.597.394
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -6.375 9.430 -40,34 563,45 -3.591.994 5.313.334
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.025 15.805 -6,09 562,65 -576.716 8.892.683
2020-05-08 2020-05-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15.000 16.830 819,67 177,82 2.667.300 2.992.711
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -9.279 0 -100,00
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -7.842 1.830 -81,08 400,16 -3.138.055 732.293
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -800 9.672 -7,64 399,41 -319.528 3.863.094
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -637 10.472 -5,73 398,71 -253.978 4.175.291
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9.279 11.109 507,05 50,91 472.394 565.559
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -5.000 1.830 -73,21 400,03 -2.000.150 732.055
2020-02-14 2020-02-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5.000 6.830 273,22 57,11 285.550 390.061
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 4.361 4.361
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 320 1.830 21,19
2019-05-31 2019-05-30 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 27.245 27.245
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3.784 3.784
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 323 1.510 27,21
2018-06-15 2018-06-13 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 27.830 27.830
2018-01-03 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7.439 7.439
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series A-1 Preferred Stock
C - Conversion -25.000 0 -100,00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
C - Conversion 25.000 3.139.043 0,80
2017-12-08 2017-12-07 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 47.165 47.165
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
6.228.086
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
6.228.086
2017-01-05 2017-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 7.830 7.830
2016-06-23 2016-06-21 4 AGIO AGIOS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 8.500 48.875 21,05
2016-06-21 2016-06-17 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2016-01-06 2016-01-04 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 9.212 9.212
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -5.000 5.000 -50,00
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -500 1.187 -29,64 595,44 -297.720 706.787
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -2.000 1.687 -54,24 593,64 -1.187.280 1.001.471
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.000 3.687 -21,34 590,17 -590.170 2.175.957
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.500 4.687 -24,24 584,07 -876.105 2.737.536
2015-08-05 2015-08-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 5.000 6.187 421,23 57,11 285.550 353.340
2015-06-25 2015-06-23 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 11.262 40.375 38,68
2015-06-16 2015-06-12 4 JUNO Juno Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12.000 12.000
2015-04-24 2015-04-23 4 PFE PFIZER INC
Phantom Stock Units
A - Award 4.596 29.100 18,75 35,36 162.500 1.028.975
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3.000 9.279 -24,43
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -300 1.187 -20,17 424,44 -127.332 503.810
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.100 1.487 -42,52 423,64 -466.004 629.953
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.600 2.587 -38,21 420,33 -672.528 1.087.394
2015-02-27 2015-02-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3.000 4.187 252,74 50,91 152.730 213.160
2015-01-05 2015-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 10.838 10.838
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -175.000 0 -100,00
2014-12-23 2014-12-23 4 JUNO Juno Therapeutics, Inc.
Common Stock
C - Conversion 175.000 250.000 233,33
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150.000
2014-12-18 3 JUNO Juno Therapeutics, Inc.
Common Stock
150.000
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3.000 12.279 -19,63
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 1.187 -71,65 352,20 -1.056.600 418.061
2014-08-27 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3.000 4.187 252,74 50,91 152.730 213.160
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.387 15.279 -8,32
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -200 1.187 -14,42 351,62 -70.324 417.373
2014-08-27 2014-08-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.387 1.387 50,91 70.612 70.612
2014-06-05 2014-05-30 4 AGIO AGIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 14.000 29.113 92,64
2014-04-28 2014-04-24 4 PFE PFIZER INC
Phantom Stock Units
A - Award 5.291 23.671 28,79 30,71 162.500 726.932
2014-04-03 2013-07-24 4 AGIO AGIOS PHARMACEUTICALS INC
Common stock
P - Purchase 55.555 101.009 122,22 18,00 999.990 1.818.162
2014-01-06 2014-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12.750 12.750
2013-12-06 2013-12-04 4 AGIO AGIOS PHARMACEUTICALS INC
Common Stock (right to buy)
A - Award 10.750 15.113 246,39
2013-07-23 3 AGIO AGIOS PHARMACEUTICALS INC
Common Stock
45.454
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -300 10.000 -2,91
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -500 10.300 -4,63
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.700 10.800 -13,60
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.700 10.800 -13,60
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -800 14.200 -5,33
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.334 16.666 -33,34
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -300 0 -100,00 264,17 -79.251
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 300 300 57,11 17.133 17.133
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -500 0 -100,00 263,50 -131.750
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 500 500 57,11 28.555 28.555
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.700 0 -100,00 262,49 -446.233
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.700 1.700 57,11 97.087 97.087
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1.700 1.700 57,11 97.087 97.087
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -1.700 0 -100,00 261,53 -444.601
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -800 0 -100,00 260,75 -208.600
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 800 800 57,11 45.688 45.688
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale -8.334 0 -100,00 260,20 -2.168.507
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 8.334 8.334 50,91 424.284 424.284
2013-04-26 2013-04-25 4 PFE PFIZER INC
Phantom Stock Units
A - Award 4.544 17.794 34,29 30,26 137.500 538.436
2013-01-03 2013-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
2012-04-27 2012-04-26 4 PFE PFIZER INC
Phantom Stock Units
A - Award 5.963 12.776 87,51 23,06 137.500 294.619
2012-01-04 2012-01-03 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 15.000 15.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)